Cash and Cash Equivalents, at Carrying Value |
17.22M |
Accounts Receivable, Net |
108.52M |
Inventory, Net |
37.34M |
Prepaid Expense and Other Assets |
TOTAL CURRENT ASSETS |
185.35M |
Property, Plant and Equipment, Net |
131.21M |
Intangible Assets, Net (Excluding Goodwill) |
10.02M |
Goodwill |
179.04M |
Deferred Tax Assets, Net, Noncurrent |
9.79M |
Other Assets, Noncurrent |
46.72M |
TOTAL ASSETS |
562.14M |
Accounts Payable, Current |
32.2M |
Employee-related Liabilities, Current |
23.54M |
Sales and Excise Tax Payable, Current |
6.82M |
Deferred Revenue, Current |
12.99M |
Taxes Payable, Current |
5.6M |
Convertible Debt, Current |
Other Accrued Liabilities, Current |
12.4M |
TOTAL CURRENT LIABILITIES |
93.54M |
Deferred Compensation Liability, Classified, Noncurrent |
45.98M |
Deferred Tax Liabilities, Noncurrent |
5.86M |
Other Liabilities, Noncurrent |
47.6M |
Commitments and Contingencies |
0 |
Temporary Equity, Redemption Value |
Preferred Stock, Value, Issued |
0 |
Common Stock, Value, Issued |
1.15M |
Additional Paid in Capital, Common Stock |
62.48M |
Retained Earnings (Accumulated Deficit) |
196.76M |
Accumulated Other Comprehensive Income (Loss), Net of Tax |
-11.25M |
Treasury shares (at cost), xxx at 2011 and 4,218,726 at 2010 |
-91.55M |
Total Core Laboratories N.V. shareholders' equity |
157.59M |
Stockholders' Equity Attributable to Noncontrolling Interest |
5.21M |
TOTAL EQUITY |
162.8M |
TOTAL LIABILITIES AND EQUITY |
562.14M |